Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2010

01-04-2010 | Original Paper

Psychosocial Factors Associated with Successful Transition into HIV Case Management for those without Primary Care in an Urban Area

Authors: Derek Johnson, Marcia Polansky, Marlene Matosky, Michelle Teti

Published in: AIDS and Behavior | Issue 2/2010

Login to get access

Abstract

The purpose of this study was to identify the psychosocial factors which influence transitioning HIV positive clients without primary medical care to a case management agency within 6 weeks by a city brokerage agency. People living with HIV who reported being in a social support group and those who requested assistance with meeting their basic needs were significantly more likely to attend their first case management appointment within 6 weeks (adjusted OR 1.91 95% CI 1.22–2.97 and OR 1.24 95% CI 1.01–1.54, respectively). Individuals requesting medical care or substance abuse treatment were less likely to accomplish transitioning (adjusted OR 0.75 95% CI 0.59–0.95 and adjusted OR 0.70 95% CI 0.53–0.91, respectively). The implications of this study for improving the effectiveness of brokering case management for those with HIV are discussed.
Literature
1.
Update to Racial/Ethnic Disparities in Diagnoses of HIV/AIDS-33 States, 2001–2005. In: A Prevention CfDCa, editor. 2007. P. 189–93.
2.
Valdiserri RO. HIV/AIDS stigma: an impediment to public health. Am J Public Health. 2002;92(3):341–2.CrossRefPubMed
3.
Mizuno Y, Wilkinson JD, Santibanez S, Dawson Rose C, Knowlton A, Handley K, et al. Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care. 2006;18(5):417–25.CrossRefPubMed
4.
Reif S, Golin CE, Smith SR. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care. 2005;17(5):558–65.PubMed
5.
Chernesky RH, Grube B. Examining the HIV/AIDS case management process. Health Soc Work. 2000;25(4):243–53.PubMed
6.
Mor V, Piette J, Fleishman J. Community-based case management for persons with AIDS. Health Aff (Millwood). 1989;8(4):139–53.CrossRef
7.
Katz MH, Cunningham WE, Fleishman JA, Andersen RM, Kellogg T, Bozzette SA, et al. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Ann Intern Med. 2001;135(8 Pt 1):557–65.PubMed
8.
Chan D, Absher D, Sabatier S. Recipients in need of ancillary services and their receipt of HIV medical care in California. AIDS Care. 2002;14(Suppl 1):S73–83.CrossRefPubMed
9.
Magnus M, Schmidt N, Kirkhart K, Schieffelin C, Fuchs N, Brown B, et al. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care STDS. 2001;15(3):137–45.CrossRefPubMed
10.
Messeri PA, Abramson DM, Aidala AA, Lee F, Lee G. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care. 2002;14(Suppl 1):S15–29.PubMedCrossRef
11.
Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423–31.CrossRefPubMed
12.
Javanbakht M, Prosser P, Grimes T, Weinstein M, Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J Int Assoc Physicians AIDS Care (Chic Ill). 2006;5(4):143–50.CrossRef
13.
Kushel MB, Colfax G, Ragland K, Heineman A, Palacio H, Bangsberg DR. Case management is associated with improved antiretroviral adherence and CD4 + cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis. 2006;43(2):234–42.CrossRefPubMed
14.
Purcell DW, DeGroff AS, Wolitski RJ. HIV prevention case management: current practice and future directions. Health Soc Work. 1998;23(4):282–9.PubMed
15.
Gasiorowicz M, Llanas MR, DiFranceisco W, Benotsch EG, Brondino MJ, Catz SL, et al. Reductions in transmission risk behaviors in HIV-positive clients receiving prevention case management services: findings from a community demonstration project. AIDS Educ Prev. 2005;17(1 Suppl A):40–52.CrossRefPubMed
16.
Myers J, Zack B, Kramer K, Gardner M, Rucobo G, Costa-Taylor S. Get connected: an HIV prevention case management program for men and women leaving California prisons. Am J Public Health. 2005;95(10):1682–4.CrossRefPubMed
17.
Bauserman RL, Richardson D, Ward M, Shea M, Bowlin C, Tomoyasu N, et al. HIV prevention with jail and prison inmates: Maryland’s prevention case management program. AIDS Educ Prev. 2003;15(5):465–80.CrossRefPubMed
18.
Robles RR, Reyes JC, Colon HM, Sahai H, Marrero CA, Matos TD, et al. Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized controlled study. J Subst Abuse Treat. 2004;27(2):145–52.CrossRefPubMed
19.
Evans KR. Ancillary services for individuals living with HIV/AIDS. Nurs Clin North Am. 2006;41(3):383–93.CrossRefPubMed
20.
Bat-Chava Y, Martin D, Kosciw JG. Barriers to HIV/AIDS knowledge and prevention among deaf and hard of hearing people. AIDS Care. 2005;17(5):623–34.PubMed
21.
Sebesta DS, Marx R, Liu Y. HIV prevention case management in San Francisco: barriers to successful implementation. AIDS Care. 2006;18(4):345–55.CrossRefPubMed
22.
Hsu JH. Substance abuse and HIV. Hopkins HIV Rep. 2002;14(4):8–12.PubMed
23.
Rapp RC, Otto AL, Lane DT, Redko C, McGatha S, Carlson RG. Improving linkage with substance abuse treatment using brief case management and motivational interviewing. Drug Alcohol Depend. 2008;94(1–3):172–82.CrossRefPubMed
24.
Terra SM. What can claims data tell the case manager? Prof Case Manag. 2008;13(4):195–208.PubMed
25.
Rosenstock L (2005) Why people use health services.
26.
Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D’Aunno TA. Linkage to medical services in the Drug Abuse Treatment Outcome Study. Med Care. 2001;39(3):284–95.CrossRefPubMed
27.
Kurtz SP, Surratt HL, Kiley MC, Inciardi JA. Barriers to health and social services for street-based sex workers. J Health Care Poor Underserved. 2005;16(2):345–61.CrossRefPubMed
28.
Young AS, Sullivan G, Bogart LM, Koegel P, Kanouse DE. Needs for services reported by adults with severe mental illness and HIV. Psychiatr Serv. 2005;56(1):99–101.CrossRefPubMed
29.
Miller MW, Vogt DS, Mozley SL, Kaloupek DG, Keane TM. PTSD and substance-related problems: the mediating roles of disconstraint and negative emotionality. J Abnorm Psychol. 2006;115(2):369–79.CrossRefPubMed
30.
Castel S, Rush B, Urbanoski K, Toneatto T. Overlap of clusters of psychiatric symptoms among clients of a comprehensive addiction treatment service. Psychol Addict Behav. 2006;20(1):28–35.CrossRefPubMed
31.
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8.CrossRefPubMed
32.
Shwartz M, Baker G, Mulvey KP, Plough A. Improving publicly funded substance abuse treatment: the value of case management. Am J Public Health. 1997;87(10):1659–64.CrossRefPubMed
33.
McLellan AT, Hagan TA, Levine M, Meyers K, Gould F, Bencivengo M, et al. Does clinical case management improve outpatient addiction treatment. Drug Alcohol Depend. 1999;55(1–2):91–103.CrossRefPubMed
34.
Crespo-Fierro M. Compliance/adherence and care management in HIV disease. J Assoc Nurses AIDS Care. 1997;8(4):43–54.CrossRefPubMed
35.
Malone SB, Osborne JJ. Improving treatment adherence in drug abusers who are HIV-positive. Lippincotts Case Manag. 2000;5(6):236–45.CrossRefPubMed
36.
Brady S, Hiam CM, Saemann R, Humbert L, Fleming MZ, Dawkins-Brickhouse K. Dual diagnosis: a treatment model for substance abuse and major mental illness. Community Ment Health J. 1996;32(6):573–8.CrossRefPubMed
37.
DiClemente CC, Nidecker M, Bellack AS. Motivation and the stages of change among individuals with severe mental illness and substance abuse disorders. J Subst Abuse Treat. 2008;34(1):25–35.CrossRefPubMed
38.
Bowlby J. Attachment and loss: sepration, anxiety and anger. New York: Basic Book; 1973.
39.
Bernard H, Burlingame G, Flores P, Greene L, Joyce A, Kobos JC, et al. Clinical practice guidelines for group psychotherapy. Int J Group Psychother. 2008;58(4):455–542.CrossRefPubMed
40.
Ognibene A, Mori F, Santoni R, Zuppiroli A, Peris A, Targioni G, et al. Cardiac troponin I in myocardial contusion. Clin Chem. 1998;44(4):889–90.PubMed
41.
Polansky MLW, Litzke C, Coulter B, Sommers L. A qualitative study of an attachment-based parenting group for mothers with drug addictions: on being and having a mother. J Soc Work Pract. 2006;2(20):115–31.CrossRef
42.
Collins NL. Working models of attachment: implications for explanation, emotion and behavior. J Pers Soc Psychol. 1996;71(4):810–32.CrossRefPubMed
43.
Thorberg FA, Lyvers M. Attachment, fear of intimacy and differentiation of self among clients in substance disorder treatment facilities. Addict Behav. 2006;31(4):732–7.CrossRefPubMed
44.
Zegers MA, Schuengel C, Van IMH, Janssens JM. Attachment and problem behavior of adolescents during residential treatment. Attach Hum Dev. 2008;10(1):91–103.CrossRefPubMed
45.
Dozier M, Cue KL, Barnett L. Clinicians as caregivers: role of attachment organization in treatment. J Consult Clin Psychol. 1994;62(4):793–800.CrossRefPubMed
46.
Roth AJ, Modi R. Psychiatric issues in older cancer patients. Crit Rev Oncol Hematol. 2003;48(2):185–97.CrossRefPubMed
47.
Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996;153(11):1430–7.PubMed
48.
Rabkin JG, Ferrando SJ, Lin SH, Sewell M, McElhiney M. Psychological effects of HAART: a 2-year study. Psychosom Med. 2000;62(3):413–22.PubMed
49.
Sarna L, van Servellen G, Padilla G. Comparison of emotional distress in men with acquired immunodeficiency syndrome and in men with cancer. Appl Nurs Res. 1996;9(4):209–12.CrossRefPubMed
50.
Nyamathi A, Flaskerud J, Leake B, Chen S. Impoverished women at risk for AIDS. Social support variables. J Psychosoc Nurs Ment Health Serv. 1996;34(11):31–9.PubMed
51.
Stowe A, Ross MW, Wodak A, Thomas GV, Larson SA. Significant relationships and social supports of injecting drug users and their implications for HIV/AIDS services. AIDS Care. 1993;5(1):23–33.CrossRefPubMed
52.
Swendeman D, Rotheram-Borus MJ, Comulada S, Weiss R, Ramos ME. Predictors of HIV-related stigma among young people living with HIV. Health Psychol. 2006;25(4):501–9.CrossRefPubMed
53.
Hogan BE, Linden W, Najarian B. Social support interventions: do they work? Clin Psychol Rev. 2002;22(3):383–442.CrossRefPubMed
54.
Hyde J, Appleby PR, Weiss G, Bailey J, Morgan X. Group-level interventions for persons living with HIV: a catalyst for individual change. AIDS Educ Prev. 2005;17(1 Suppl A):53–65.CrossRefPubMed
55.
Himelhoch S, Medoff DR, Oyeniyi G. Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDS. 2007;21(10):732–9.CrossRefPubMed
56.
Carrico AW, Antoni MH. Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials. Psychosom Med. 2008;70(5):575–84.CrossRefPubMed
57.
Capitanio J. AIDS stigma and sexual prejudice. Am Behav Sci. 1999;2(42):1130–47.
58.
Herek GM, Mitnick L, Burris S, Chesney M, Devine P, Fullilove MT, et al. Workshop report: AIDS and stigma: a conceptual framework and research agenda. AIDS Public Policy J. 1998;13(1):36–47.PubMed
59.
Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, et al. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 2007;32(7):1331–46.CrossRefPubMed
60.
Nickel JT, Salsberry PJ, Caswell RJ, Keller MD, Long T, O’Connell M. Quality of life in nurse case management of persons with AIDS receiving home care. Res Nurs Health. 1996;19(2):91–9.CrossRefPubMed
Metadata
Title
Psychosocial Factors Associated with Successful Transition into HIV Case Management for those without Primary Care in an Urban Area
Authors
Derek Johnson
Marcia Polansky
Marlene Matosky
Michelle Teti
Publication date
01-04-2010
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2010
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-009-9628-9

Other articles of this Issue 2/2010

AIDS and Behavior 2/2010 Go to the issue

Original Research

Clinical Correlates of HIV-Associated Neurocognitive Disorders in South Africa

Review Paper

AIDS Denialism and Public Health Practice

Original Research

Stress Biomarkers as Outcomes for HIV+ Prevention: Participation, Feasibility and Findings Among HIV+ Latina and African American Mothers

Original Research

Stress, Substance Use and Sexual Risk Behaviors Among Primary Care Patients in Cape Town, South Africa

OriginalPaper

Religious Coping and Physiological, Psychological, Social, and Spiritual Outcomes in Patients with HIV/AIDS: Cross-sectional and Longitudinal Findings

Original Paper

Depression Symptoms and Treatment Among HIV Infected and Uninfected Veterans
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits